New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ascendis Pharma A/S
ASND
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

9B

Biotechnology

Next Earning date - 30 Apr 2025

9B

Biotechnology

Next Earning date - 30 Apr 2025

144.08USD

Shape1.59 ( 1.12%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

70
favorite-chart

Volume Buzz

23%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated February 17, 2025
1W 20.56 % 1M 9.93 % 3M 18.10 % 1Y -8.09 %

Key Metrics

Shape
  • Market Cap

    8.62B


  • Shares Outstanding

    59.84M


  • Share in Float

    59.14M


  • Dividende

    0


  • Earning Date

    30 Apr 2025


  • Price Target

    144.08


  • Average Volume

    448695


  • Beta

    0.637


  • Range

    111.09-161


  • Industry

    Biotechnology


  • Website

    https://ascendispharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ASND

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$564M

Shape224%

2025-Revenue

$3.87

Shape-478%

2025-EPS

$541M

Shape-1327%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Cowen & Co.

upgrade

Previous: Buy

2024-06-25

Now: Positive

Cowen & Co.

upgrade

Previous: Not converted

2024-06-25

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-2.12
vs -2.48

Q2.23

arrow
arrow

N/A

-2.35
vs -1.54

Q3.23

arrow
arrow

N/A

-3.12
vs -3.05

Q4.23

arrow
arrow

N/A

-1.66
vs -3.78

Q1.24

arrow
arrow

N/A

-2.48
vs -2.12

Q2.24

arrow
arrow

N/A

-2.05
vs -2.35

Q3.24

arrow
arrow

N/A

-1.89
vs -3.12

Q4.24

arrow
arrow

N/A

-0.67
vs -1.66

Q1.25

arrow
arrow

N/A

-1.41
vs -2.48

Q2.25

arrow
arrow

N/A

-1.19
vs -2.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+392%

33.6M  vs 6.8M

Q2.23

arrow
arrow

+669%

47.4M  vs 6.2M

Q3.23

arrow
arrow

+214%

48M  vs 15.3M

Q4.23

arrow
arrow

+501%

137.7M  vs 22.9M

Q1.24

arrow
arrow

+185%

95.9M  vs 33.6M

Q2.24

arrow
arrow

-24%

36M  vs 47.4M

Q3.24

arrow
arrow

+20%

57.8M  vs 48M

Q4.24

arrow
arrow

+26%

173.9M  vs 137.7M

Q1.25

arrow
arrow

-1%

95.2M  vs 95.9M

Q2.25

arrow
arrow

+249%

125.7M  vs 36M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-66%

-0.66
vs -0.79

Q2.23

arrow
arrow

-187%

-1.87
vs -0.66

Q3.23

arrow
arrow

+221%

2.21
vs -1.87

Q4.23

arrow
arrow

+60%

0.6
vs 2.21

Q1.24

arrow
arrow

+55%

0.55
vs 0.6

Q2.24

arrow
arrow

+34%

0.34
vs 0.55

Q3.24

arrow
arrow

+102%

1.02
vs 0.34

Q4.24

arrow
arrow

+36%

0.36
vs 1.02

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

179

179
vs 204

-12%

Q2.23

arrow
arrow

175

175
vs 179

-2%

Q3.23

arrow
arrow

174

174
vs 175

-1%

Q4.23

arrow
arrow

202

202
vs 174

16%

Q1.24

arrow
arrow

205

205
vs 202

1%

Q2.24

arrow
arrow

215

215
vs 205

5%

Q3.24

arrow
arrow

235

235
vs 215

9%

Q4.24

arrow
arrow

221

221
vs 235

-6%

Earnings Growth

Latest News